Fiscal 2023: Proven resilience during transitional year

The Group reported financial results for 2023 in line with its guidance published in August despite a challenging market environment, thus demonstrating the robustness of its business model.

Key facts and Forecast

Financial results of fiscal 2023

  • Net sales decrease organically by 1.6% to € 21.0 billion
  • EBITDA pre down organically by 9.0% to € 5.9 billion
  • “Transitional year” 2023 characterized by demanding market conditions in Life Science and Semiconductor Materials
  • Strong sales and earnings performance of Healthcare demonstrates benefits of diversified business model of the Group
  • Stable dividend proposal: € 2.20 per share

Forecast for fiscal 2024

  • Return to organic growth expected in 2024
  • Sales and EBITDA pre: slight to moderate organic growth

Overview: business performance in fiscal 2023

 

Fiscal 2023 (in € billion)

Change (in %, compared to 2022)

Organic change  (in %, compared to 2022)

Group net sales

21.0      

-5.6

-1.6

EBITDA pre

5.9

‑14.2

‑9.0

Life Science sales

9.3

-10.6

-7.9

Healthcare sales

8.1

2.7

8.5

Electronics sales

3.7

‑8.8

‑5.1

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

We delivered solid results in a transitional year 2023 despite difficult market conditions. Now, we are fully focusing on gradually returning to growth during fiscal 2024.

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Conference calls for the media and analysts

Related News

View All News
  1. Press Releases

    Fiscal 2023: Proven Resilience During Transitional Year

    The Group demonstrated the robustness of its diversified business model in a challenging market environment.

    2024/03/07

Upcoming Events

View All Events

Esther Döringer

Financial Communications

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price